MIRA INFORM REPORT

 

 

Report Date :           

25.08.2011

 

IDENTIFICATION DETAILS

 

Name :

DANSK VILOMIX AS

 

 

Registered Office :

Sjellebrovej 10, Morke, 8544

 

 

Country :

Denmark

 

 

Financials (as on) :

31.12.2010

 

 

Year of Establishment :

1983

 

 

Com. Reg. No.:

70649217

 

 

Legal Form :

Private Subsidiary Company

 

 

Line of Business :

Health Foods/Vitamins

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2011

 

Country Name

Previous Rating

                   (31.12.2010)                  

Current Rating

(31.03.2011)

Denmark

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 Bottom of Form

 

Company name & address 

 

Dansk Vilomix A/S

Sjellebrovej 10

Morke, 8544

Denmark

 Tel:      +45 86 97 41 00

Fax:      +45 86 97 40 88

 Web:   www.Vilomix.dk

 

 

Synthesis     

 

Employees:                  35

Company Type:            Private Subsidiary

Corporate Family:          5 Companies

Ultimate Parent:             Danish Agro a.m.b.a.

Incorporation Date:         1983   

Financials in:                 USD (Millions)

Fiscal Year End:            31-Dec-2010

Reporting Currency:       Danish Krone

Annual Sales:               134.4

Net Income:                  6.2

Total Assets:                45.3

 

 

Business Description     

 

Health Foods/Vitamins

 

Industry

Industry            Biotechnology and Drugs

ANZSIC 2006:    184 - Pharmaceutical and Medicinal Product Manufacturing

NACE 2002:      244 - Manufacture of pharmaceuticals, medicinal chemicals and botanical products

NAICS 2002:     32541 - Pharmaceutical and Medicine Manufacturing

UK SIC 2003:    244 - Manufacture of pharmaceuticals, medicinal chemicals and botanical products

US SIC 1987:    2099 - Food Preparations, Not Elsewhere Classified

 

           

Key Executives   

 

Name

Title

Peter Iversen

Managing Director

Henning Haahr

Financial Director

Søren Aage Rathcke

Board Member

Carsten Kildegaard Lauridsen

Bestyrelsesnæstformand

Christian Pagaard Junker

Bestyrelsesformand

 

 

Corporate Overview

 

Location

Sjellebrovej 10

Morke, 8544

Denmark

Tel:       +45 86 97 41 00

Fax:      +45 86 97 40 88

Web:    www.Vilomix.dk

           

Sales DKK(mil):             755.6

Assets DKK(mil):           251.4

Employees:                   35

Fiscal Year End:            31-Dec-2010

Industry:                        Biotechnology and Drugs

Incorporation Date:         1983

Company Type:             Private Subsidiary

Quoted Status:              Not Quoted

Registered No.(DNK):     70649217

Managing Director:         Peter Iversen

 

Contents

·         Industry Codes

·         Business Description

·         Financial Data

 

Industry Codes

 

ANZSIC 2006 Codes:

184       -          Pharmaceutical and Medicinal Product Manufacturing

1192     -          Prepared Animal and Bird Feed Manufacturing

 

NACE 2002 Codes:

244       -          Manufacture of pharmaceuticals, medicinal chemicals and botanical products

157       -          Manufacture of prepared animal feeds

 

NAICS 2002 Codes:

31111   -          Animal Food Manufacturing

32541   -          Pharmaceutical and Medicine Manufacturing

 

US SIC 1987:

2099     -          Food Preparations, Not Elsewhere Classified

2047     -          Dog and Cat Food

 

UK SIC 2003:

244       -          Manufacture of pharmaceuticals, medicinal chemicals and botanical products

157       -          Manufacture of prepared animal feeds

 

Business Description

Health Foods/Vitamins

 

Financial Data

Financials in:

DKK(mil)

 

Revenue:

755.6

Net Income:

35.1

Assets:

251.4

Total Liabilities:

0.0

 

 

 

Date of Financial Data:

31-Dec-2010

 

1 Year Growth

NA

NA

NA

 

 

Corporate Family

Corporate Structure News:

 

Danish Agro a.m.b.a.
Dansk Vilomix A/S

Total Corporate Family Members: 5 

 

 

 

Company Name

Company Type

Location

Country

Industry

Sales
(USD mil)

Employees

Danish Agro a.m.b.a.

Parent

Karise

Denmark

Construction and Agriculture Machinery

556.6

394

DLA Agro A.m.b.A

Subsidiary

Galten

Denmark

Chemical Manufacturing

750.6

44

Dansk Vilomix A/S

Subsidiary

Mørke

Denmark

Biotechnology and Drugs

134.4

35

Danish Agro Byggecenter A/S

Subsidiary

Bjæverskov

Denmark

Retail (Home Improvement)

5.8

12

Dpl Invest A/S (Investeringsselskabet For Dansk Primær Landbrug)

Subsidiary

Silkeborg

Denmark

Miscellaneous Financial Services

39.1

5

Executive report

 

Board of Directors

 

Name

Title

Function

 

Søren Aage Rathcke

 

Board Member

Director/Board Member

 

Carsten Kildegaard Lauridsen

 

Bestyrelsesnæstformand

Director/Board Member

 

Christian Pagaard Junker

 

Bestyrelsesformand

Director/Board Member

 

 

Executives

 

Name

Title

Function

 

Peter Iversen

 

Managing Director

Chief Executive Officer

 

Henning Haahr

 

Financial Director

Finance Executive

 

 

 

Annual Profit & Loss

 

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

Filed Currency

DKK

DKK

DKK

Exchange Rate (Period Average)

5.623146

5.354263

5.097335

Consolidated

No

No

No

 

 

 

 

Total Revenue

134.4

114.5

105.2

Gross Profit

13.5

11.1

8.5

Operating Income

8.0

6.4

3.9

Net Income

6.2

5.0

2.9

 

 

Annual Balance Sheet

 

Financials in: USD (mil)

 

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

Filed Currency

DKK

DKK

DKK

Exchange Rate

5.55485

5.18625

5.35465

Consolidated

No

No

No

 

 

 

 

Total Assets

45.3

34.5

26.2

Provisions

1.4

1.0

0.9

Total Liabilities

-

21.6

17.9

Total Equity

12.9

11.9

7.4

 

 

 

Annual Ratios

 

 

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

Filed Currency

-

-

-

Exchange Rate

-

-

-

Consolidated

No

No

No

 

 

 

 

Operating Margin

5.98

5.56

3.71

Current Ratio

129.87

139.00

129.61

Total debt/total equity

28.45

34.41

28.34

Return on average equity

49.14

43.78

37.71

 

 

Annual Growth Rates

 

 

 

 

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

Filed Currency

-

-

Exchange Rate

-

-

Consolidated

No

No

 

 

 

Turnover Percent Change

23.26%

14.31%

Marginal Contribution Percent Change

27.60%

37.34%

Operating Results Percent Change

32.68%

71.12%

Profit/Loss for the Year Percent Change

30.52%

79.41%

Assets Percent Change

40.65%

27.31%

Provisions Percent Change

60.00%

-

Debts Percent Change

-

17.40%

Equity Capital Percent Change

16.27%

54.56%

Operating Margin Percent Change

7.55%

49.87%

Current Ratio Percent Change

-6.57%

7.24%

Debt/Equity Ratio Percent Change

-17.32%

21.42%

Retun On Equity Percent Change

12.24%

16.10%

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.45.77

UK Pound

1

Rs.75.58

Euro

1

Rs.65.97

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.